accountn"May 2 (Reuters) - The U.S. health regulator on Monday approved Boehringer Ingelheim's and Eli Lilly's diabetes drug Tradjenta. The drug is to be used with diet and exercise to improve blood glucose control in adults with type-2 diabetes. In January,...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 1-FDA approves Boehringer, Lilly's diabetes drug Tradjenta
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account